Abstract
Background We sought to examine whether characteristics, implant strategy, and outcomes in patients who receive continuous-flow left ventricular assist devices (CF-LVAD) differ across geographic regions in the United States (US).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have